| Award Mechanism |
Eligibility |
Key Mechanism Elements |
Funding |
| Concept Award (to be offered in April 2010) |
Investigators at all academic levels (or equivalent) |
- Supports the exploration of a highly innovative new concept or untested theory that addresses an
important problem relevant to breast cancer
- Supports high-risk studies that have the potential to reveal new avenues for investigation
- Preliminary data not allowed
|
- Maximum funding of $75K for direct costs (plus indirect costs)
- Period of performance not to exceed 1 year
|
| Era of Hope Scholar Award |
Independent, non-mentored investigators within 6 years of their last mentored position as of the application
submission deadline |
- Supports exceptionally talented, creative early-career scientists who have demonstrated that they are the
"best and brightest" in their fields
- Individuals should exhibit strong potential for leadership in the breast cancer community
|
- Maximum funding of $2.5M for direct costs (plus indirect costs)
- Period of performance not to exceed 5 years
|
| Idea Award |
- Investigators at all academic levels (or equivalent)
- Postdoctoral-level investigators are eligible and are encouraged to apply
|
- Supports conceptually innovative, high-risk/high-reward research from all areas of basic, translational,
clinical, behavioral, and epidemiological research
- Innovation is the most important review criterion
- Preliminary data not consistent with intent of the award mechanism; strength of proposal should not rely
on preliminary data
- Collaborative Option supports combining expertise of two Principal Investigators to more effectively
address an innovative research question
|
- Maximum funding of $375K for direct costs (plus indirect costs) Period of performance not to exceed 2 years
- For Collaborative Option: Maximum funding of $550K for direct costs (plus indirect costs) Period of
performance not to exceed 2 years
- For Population-Based Studies: Maximum funding of $750K for direct costs (plus indirect costs) Period of
performance not to exceed 4 years
|
| Innovator Award |
Associate Professor or above (or equivalent) |
- Supports visionary individuals who have demonstrated creativity, innovative work, and leadership in any
field
- Provides opportunity to pursue novel, visionary, high-risk ideas that could ultimately lead to the
eradication of breast cancer
|
- Maximum funding of $5M for direct costs (plus indirect costs)
- Period of performance not to exceed 5 years
|
| Inter-Institutional Training Award |
- Principal Investigator/Co-investigator(s): Faculty members with doctoral degrees who are at an
institution that does not have an established breast cancer research program
- Mentor(s): Must be part of an established breast cancer research program at the mentoring institution
|
- Supports two or more faculty-level investigators at an organization that does not currently have a breast
cancer research program to acquire mentored training in breast cancer research
- Supports the establishment of a sustainable breast cancer research program at the applicant organization
- Proposed research and training should lead to publication(s) and independent breast cancer research funding
- Preproposal is required; proposal submission is by invitation only
|
- Maximum funding of $1M for direct costs (plus indirect costs)
- Period of performance not to exceed 4 years
|
| Multi-Team Award |
- Three independent, faculty-level (or equivalent) investigators
- Must include a basic investigator, a clinical investigator, and an investigator from any other area of
expertise
|
- Supports three innovative investigators and their research teams in a coordinated and integrated
translational research effort to address a question of major importance in breast cancer
- Teams must include consumer advocates
- Multiple institutions must be involved
- A clear plan for intensive collaboration among the teams must be demonstrated
- Regular in-person meetings and on-site cross-training of investigators among the research teams will be
required
- Preproposal is required; proposal submission is by invitation only
|
- Maximum funding of $300K for direct costs (plus indirect costs)
- Period of performance not to exceed 3 years
|
| Postdoctoral Fellowship Award |
- Principal Investigator: Graduate student enrolled in a PhD or MD/PhD program
- No more than 2 years in the proposed research setting and no more than 4 years' postdoctoral research
experience
- Mentor or formal co-mentor: Must have breast cancer experience, to include current funding and publications
|
- Supports the training of exceptionally talented recent doctoral graduates
- Proposed research should be innovative and have the potential for high impact
- Multidisciplinary training encouraged
- Training program and mentorship should prepare the PI for an independent career at the forefront of
breast cancer research
|
- Maximum funding of $300K for direct costs (plus indirect costs)
- Period of performance not to exceed 3 years
|
| Predoctoral Traineeship Award |
- Principal Investigator: Graduate student enrolled in a PhD or MD/PhD program
- Mentor or formal co-mentor: Must have breast cancer experience, to include current funding and publications
|
- Supports the training of promising graduate students studying breast cancer research under the guidance
of a designated mentor
- The predoctoral trainee is considered the PI and should write the proposal with appropriate direction from the mentor
- Training program and mentorship should facilitate development of the PI as a breast cancer researcher
|
- Maximum funding of $120K for direct costs (plus indirect costs)
- Period of performance not to exceed 3 years
|
| Transformative Vision Award |
Investigators at all academic levels (or equivalent) |
- Supports research programs that have an extraordinary vision for dramatically transforming the prevention or
treatment of breast cancer and a plan to test and implement the vision as quickly as possible
- Focuses on achieving a visionary solution to a problem or question of overarching importance to breast
cancer through an investigator-defined approach
- Preproposal is required; proposal submission is by invitation only
|
- Maximum funding of $12M for direct costs (plus indirect costs)
- Period of performance not to exceed 5 years
|
